Share this Post!

The Food and Drug Administration (FDA) and the Philippine National Police – Criminal Investigation Detection Group (PNP-CIDG) conducted a joint operation targeting the sale and distribution of unregistered, counterfeit, and potentially harmful health products in North Luzon last 18 April 2024.

This operation is part of FDA’s Oplan Katharos which is a measure by the agency to develop and implement more efficient guidelines in relation to proper handling, storage, and disposal of seized health products.

FDA Regional Enforcement Unit – North Luzon Cluster (FDA REU – NLC) agents Special Investigator I Gil B. Magno and Mark C. Tamayo, led by Special Investigator II Mark Lester M. Lasam, and the PNP CIDG RFU2, under PMajor James John M. Taguba conducted the joint operation at Barangay Casala, San Mariano, Isabela.

The team seized health products identified as unregistered with the FDA, under the watch of Barangay Kagawad Marilou C. Dacumos. The violative food and household urban pesticide products with an estimated value of ₱249,125.00 were seized, inventoried, and sealed.

Following the operation, the FROO-NLC Post-monitoring Team confirmed that the violative health products originated from a warehouse in Santiago, Isabela. While the supplier identified the warehouse’s operations, further investigation is underway to ascertain its exact location and ownership details.

This joint effort between the FDA and PNP-CIDG underscores their unwavering commitment to upholding public health standards and safeguarding consumers from the risks posed by violative health products.

Through the intensification of FDA’s collaboration and vigilance, the agency remains dedicated to combating the proliferation of unregistered and counterfeit health products through programs like Oplan Katharos to ensure the safety of the public.

See more:->